Atlas Trials

Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission

Clinical trial NCT01982487 · WITHDRAWN

Trial details

NCT number
NCT01982487
Sponsor
Roswell Park Cancer Institute
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity CancerStage IA Fallopian Tube CancerStage IA Ovarian Epithelial CancerStage IA Primary Peritoneal Cavity CancerStage IB Fallopian Tube CancerStage IB Ovarian Epithelial CancerStage IB Primary Peritoneal Cavity CancerStage IC Fallopian Tube CancerStage IC Ovarian Epithelial CancerStage IC Primary Peritoneal Cavity Cancer
Start date
2013-12-01
Primary completion
2017-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.